Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
-11.6M
-
Total reported value, excl. options
-
$18M
-
Value change
-
-$12.3M
-
Number of buys
-
28
-
Number of sells
-
-46
-
Price
-
$0.71
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2016
82 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2016.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
of 123M outstanding shares and own 20.58% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (8.2M shares), BAKER BROS. ADVISORS LP (5.12M shares), VANGUARD GROUP INC (2.91M shares), Point72 Asset Management, L.P. (2.37M shares), TANAKA CAPITAL MANAGEMENT INC (653K shares), MILLENNIUM MANAGEMENT LLC (648K shares), GSA CAPITAL PARTNERS LLP (620K shares), BlackRock Institutional Trust Company, N.A. (469K shares), GEODE CAPITAL MANAGEMENT, LLC (460K shares), and CREDIT SUISSE AG/ (425K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.